Vitarka Therapeutics
PrivateLast Round
Grant
Jun 1, 2023
Total Funding Raised
$2.92M
Company Overview
Vitarka Therapeutics operates in Healthcare & Life Sciences and is based in Sandwich. Its latest recorded funding round was a Grant round in June 2023.
Vitarka Therapeutics is a biotechnology company developing a targeted non-viral delivery platform designed for intracellular targets in neuroscience and neurodegeneration.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vitarka Therapeutics Comparables
Compare Vitarka Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sapreme Technologies BV | 86% | |
| Sixfold Bioscience | 86% | |
| iDEL Therapeutics | 80% |
For institutional investors. Book with your work email.
Vitarka Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2023 | ||||
| Seed | Apr 6, 2023 | ||||
| Grant | Mar 1, 2023 | ||||
| Grant | Nov 1, 2022 | ||||
| Seed | May 9, 2022 |
For institutional investors. Book with your work email.
Vitarka Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Seed, Grant |
| IndieBio | Accelerator |
| UK Innovation & Science Seed Fund | Seed |
| SOSV | Seed, Accelerator |
| Discovery Park Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 9, 2024
Monthly visitors increased 676% MoM.
- Jun 1, 2023
$540K raised in grant funding.
For institutional investors. Book with your work email.
Vitarka Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vitarka Therapeutics's valuation, stock price, and market status.
Is Vitarka Therapeutics a public or private company?
Vitarka Therapeutics is a private company.
What is the current stock price of Vitarka Therapeutics?
Vitarka Therapeutics is a private company, so its shares have no public market price. Caplight tracks Vitarka Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vitarka Therapeutics worth (valuation)?
Valuation information for Vitarka Therapeutics is not publicly available.
Can I buy Vitarka Therapeutics stock?
Vitarka Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vitarka Therapeutics's last funding round?
Vitarka Therapeutics's most recent funding round was Grant on June 1, 2023.
Who are the main investors in Vitarka Therapeutics?
Key investors in Vitarka Therapeutics include IndieBio, Discovery Park Ventures.
Will Vitarka Therapeutics IPO soon?
No public IPO plans have been announced for Vitarka Therapeutics.
How can I track Vitarka Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Vitarka Therapeutics's shares on secondary markets.